Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

Corcept Therapeutics Incorporated (CORT)

-NasdaqCM

1.81 Down 0.07(3.72%) 3:59PM EDT|After Hours : 1.80 0.00 (0.00%) 4:00PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 3,307   -   -  
Cost of Revenue91   -   -  
Gross Profit 3,216   -   -  
Operating Expenses
Research Development14,074  21,001  18,949  
Selling General and Administrative25,414  11,331  8,488  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (36,272) (32,332) (27,437)
Income from Continuing Operations
Total Other Income/Expenses Net -  3  1,496  
Earnings Before Interest And Taxes(36,272)(32,329)(25,941)
Interest Expense1,776  25  25  
Income Before Tax(38,048)(32,354)(25,966)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(38,048)(32,354)(25,966)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (38,048) (32,354) (25,966)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (38,048) (32,354) (25,966)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.